Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 17, 2007
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect
Cheri Enders Klein, Yi-Lin Chiu, Walid Awni, et al.
Clinical Child and Family Psychology Review
|
June 2, 2009
Parental exposure to mass violence and child mental health: the First Responder and WTC Evacuee Study
Christina W Hoven, Cristiane S Duarte, Ping Wu, et al.
Journal of Clinical Pharmacology
|
April 29, 2008
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir
Cheri E Klein, Yi-Lin Chiu, Yan Cai, et al.
Journal of Pathology and Translational Medicine
|
June 20, 2017
HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, et al.
Metabolic Syndrome and Related Disorders
|
May 2, 2023
Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review
Monique Ferguson, Jaysonn Vel, Vincent Phan, et al.
The Lancet. Rheumatology
|
January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
Roy Fleischmann, Alan Friedman, Edit Drescher, et al.
Advances in Therapy
|
April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a Trial
Laurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology
|
August 1, 2020
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial
Baili Chen, Xiang Gao, Jie Zhong, et al.
International Review of Psychiatry (Abingdon, England)
|
June 24, 2008
Worldwide child and adolescent mental health begins with awareness: a preliminary assessment in nine countries
Christina W Hoven, Thao Doan, George J Musa, et al.
Psychiatry Research
|
October 26, 2010
Attention orientation in parents exposed to the 9/11 terrorist attacks and their children
Kara M Lindstrom, Donald J Mandell, George J Musa, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 17, 2007
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect
Cheri Enders Klein, Yi-Lin Chiu, Walid Awni, et al.
Clinical Child and Family Psychology Review
|
June 2, 2009
Parental exposure to mass violence and child mental health: the First Responder and WTC Evacuee Study
Christina W Hoven, Cristiane S Duarte, Ping Wu, et al.
Journal of Clinical Pharmacology
|
April 29, 2008
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir
Cheri E Klein, Yi-Lin Chiu, Yan Cai, et al.
Journal of Pathology and Translational Medicine
|
June 20, 2017
HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, et al.
Metabolic Syndrome and Related Disorders
|
May 2, 2023
Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review
Monique Ferguson, Jaysonn Vel, Vincent Phan, et al.
The Lancet. Rheumatology
|
January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
Roy Fleischmann, Alan Friedman, Edit Drescher, et al.
Advances in Therapy
|
April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a Trial
Laurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology
|
August 1, 2020
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial
Baili Chen, Xiang Gao, Jie Zhong, et al.
International Review of Psychiatry (Abingdon, England)
|
June 24, 2008
Worldwide child and adolescent mental health begins with awareness: a preliminary assessment in nine countries
Christina W Hoven, Thao Doan, George J Musa, et al.
Psychiatry Research
|
October 26, 2010
Attention orientation in parents exposed to the 9/11 terrorist attacks and their children
Kara M Lindstrom, Donald J Mandell, George J Musa, et al.
Page
of 5